Visit Corning Life Sciences at SLAS2016

The road to developing a new medicine can have many unexpected twists and turns along the way. Corning solutions can help you optimize your assays and streamline high throughput screening, so you can focus on the discovery and development of new ways to prevent and treat disease.

Visit Corning at SLAS2016, exhibit 1231 to learn more about its solutions for drug screening, lab automation, 3D cell culture and cancer research.

Plus, look out for the following Podium Talks and Poster Presentations:

Podium Talks

Automating Phenotypic and Target-based Discovery Using Parallel Automated Approaches

Addressing the Challenges of 1536 Cell-based Screening

January 25 | 12 to 12:30 p.m.

Presented by: Helen Plant, Scientist, AstraZeneca Pharmaceuticals, Macclesfield, Alabama, United Kingdom

Phenotypic, Model Organism and High Content Screening Assays

Enabling 3D Cell-based Spheroid HTS Assays in 384- and 1536-well Plate Formats

January 26 | 11:30 a.m. to 12:00 p.m.

Presented by: Franck G. Madoux, Ph.D., Senior Scientist, The Scripps Research Institute, Jupiter, Florida

Poster Presentations

Monday, January 25 | 1:00 to 3:00 p.m.

• Poster #2039 | In Vitro Hepatotoxicity Profiling Using Corning® Epic® Label-free Technology with Primary Hepatocytes, HepG2 Cells, and Corning HepatoCells

Presented by: David Randle, PhD – Applications Development Manager, Corning Incorporated, Life Sciences

• Poster #2041 | High Content Screening of Corning® HepatoCells for Hepatotoxicity

Presented by: Hannah Gitschier – Senior Applications Scientist, Corning Incorporated, Life Sciences

• Poster #4005 | Validation of Th17 Cell Differentiation from Peripheral Blood CD4+ T Cells Through Assessment of mRNA Expression and Cytokine Secretion using Microplate Reading and Cellular Imaging

Presented by: Brad Larson, Principal Scientist, BioTek Instruments, Inc.

Tuesday, January 26 | 1:00 to 3:00 p.m.

• Poster #2000 | Cancer Therapeutic Screening in Tumor Spheroids Co-cultured with Fibroblast and Immune Cells using Corning® Spheroid Microplates

Presented by: David Randle, PhD – Applications Development Manager, Corning Incorporated, Life Sciences

• Poster #2002 | Three Dimensional Hepatotoxicity Screening using Corning® HepatoCells, the Corning® Spheroid Microplate, and the SCREEN-WELL® Hepatotoxicity library

Presented by: Hannah Gitschier – Senior Applications Scientist, Corning Incorporated, Life Sciences

• Poster #2008 | A Novel Hepatocyte-like Cell as an In Vitro Screening Tool for Drug ADME/Tox Studies

Presented by: Rongjun Zuo – Senior Development Scientist, Corning Incorporated, Life Sciences

• Poster #4002 | Image-Based Analysis of a Human Neurosphere Stem Cell Model for the Evaluation of Potential Neurotoxicants

Presented by: Brad Larson, Principal Scientist, BioTek Instruments, Inc.

Find out more about Corning at SLAS2016 here.